National Heart, Lung, and Blood Institute; Notice of Closed Meeting
| Citation | 85 FR 55682 |
| Record Number | 2020-19835 |
| Published date | 09 September 2020 |
| Section | Notices |
| Court | National Institutes Of Health |
55682
Federal Register / Vol. 85, No. 175 / Wednesday, September 9, 2020 / Notices
IV. Electronic Access
Persons with access to the internet
may obtain COVID–19-related guidances
at:
•The FDA web page entitled
‘‘COVID–19-Related Guidance
Documents for Industry, FDA Staff, and
Other Stakeholders,’’ available at
https://www.fda.gov/emergency-
preparedness-and-response/mcm-
issues/covid-19-related-guidance-
documents-industry-fda-staff-and-other-
stakeholders;
•the FDA web page entitled ‘‘Search
for FDA Guidance Documents’’
available at https://www.fda.gov/
regulatory-information/search-fda-
guidance-documents; or
•https://www.regulations.gov.
Dated: September 2, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–19883 Filed 9–8–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Disease Modifying Therapies for Chronic
Lung Diseases.
Date: October 8, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–B,
Bethesda, MD 20892, (301) 827–7953,
kristen.page@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 2, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19835 Filed 9–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel Completion of
Ongoing MFMU Network Protocols.
Date: October 30, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Child Health
and Human Development, 6710B Rockledge
Drive, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Helen Huang, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6710B Rockledge Drive,
Bethesda, MD 20817, (301) 435–8380,
helen.huang@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Intellectual and
Developmental Disabilities Research Centers
[IDDRC] FY 2021 (P50).
Date: November 19–20, 2020.
Time: 8:00 a.m. to 5:00 p.m..
Agenda: To review and evaluate grant
applications.
Place: National Institute of Child Health
and Human Development, 6710B Rockledge
Drive, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Clayton W. Mash, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6710B Rockledge Drive,
Bethesda, MD 20892, (301) 496–6866,
mashc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: September 2, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19833 Filed 9–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group Molecular
Neurogenetics Study Section.
Date: October 8–9, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mary G. Schueler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7846, Bethesda, MD 20892, (301) 915–
6301, marygs@csr.nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Enabling Bioanalytical and
Imaging Technologies Study Section.
Date: October 8–9, 2020.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014 17:06 Sep 08, 2020 Jkt 250001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\09SEN1.SGM 09SEN1
